The American Society for Radiation Oncology (ASTRO) has selected C.M. Charlie Ma, PhD, Professor, Vice Chair of the Department of Radiation Oncology, and Director of Medical Physics at Fox Chase Cancer Center, as one of their 2014 Fellows. The distinguished members selected to receive the Fellow of ASTRO designation will be honored during an awards ceremony on Tuesday, September 16, at the ASTRO's 56th Annual Meeting in San Francisco, CA.
"The ASTRO Fellows designation is a great honor and we are thrilled that one of our own has been chosen," says Eric Horwitz, MD, Chair of the Department of Radiation Oncology at Fox Chase. "Charlie has made significant contributions not only to our Center, but to the field of radiation as a whole."
Awarded annually since 2006, the Fellows Program honors radiation oncology leaders who have been an ASTRO member for at least 15 years, who have contributed the equivalent of 10 years of service to ASTRO and who have made substantial contributions to the field of radiation oncology in the areas of research, education, patient care or service, and leadership. Including the 2014 Class of 30 Fellows, 242 of ASTRO's more than 10,000 members worldwide have received the designation.
Candidates are nominated by a current ASTRO Fellow and supported by three additional ASTRO members. A 10-member Fellows Selection Committee reviewed all of the nominations and presented a slate of recommended Fellows to ASTRO's Board of Directors for final approval.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at http://www.